Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 4Phase 2/3 2Phase 2 2Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Pain, Postoperative 2Depression 2Agnosia 2Prostatic Neoplasms 1Postoperative Analgesia 1Neoplasms 1Breast Neoplasms 1

Interventions

Oxygen 2Melatonin 2Ketamine 2Ultraviolet Therapy 1Surveys and Questionnaires 1Saline Solution 1Referral and Consultation 1Psychotherapy, Group 1Mindfulness-Based Stress Reduction 1Milnacipran 1Methylphenidate 1Fatty Acids, Omega-3 1Desvenlafaxine Succinate 1Cognitive Behavioral Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Depression × Ketamine × Clear all
NCT02783430 2025-12-16

KETAPAL

University Hospital, Lille

Phase 2/3 Completed
42 enrolled

Depression, Neoplasms

NCT03086148 2020-07-07

Ketamine and Postoperative Depressive Symptom-PASSION

Beijing Tiantan Hospital

Phase 2/3 Completed
84 enrolled

Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡